Page 209 - Read Online

FUTURE DIRECTIONS 13. Frucht H, Gazdar AF, Park JA, Oie H, Jensen RT. Characterization
of functional receptors for gastrointestinal hormones on human
colon cancer cells. Cancer Res 1992;52:1114-22.
It is clear that muscarinic receptors and ligands play key 14. Frucht H, Jensen RT, Dexter D, Yang WL, Xiao Y. Human colon
roles in CRC progression. Unfortunately, there are no cancer cell proliferation mediated by the M3 muscarinic cholinergic
published translational and clinical studies at this time. receptor. Clin Cancer Res 1999;5:2532-9.
Future studies focused on determining overexpression of 15. Yang WL, Frucht H. Cholinergic receptor up-regulates COX-2
muscarinic receptors in different patient cohorts, relation expression and prostaglandin E(2) production in colon cancer cells.
to CRC staging, tumor differentiation and prognosis will Carcinogenesis 2000;21:1789-93.
shed more lights in the importance of muscarinic receptor 16. Grando SA. Biological functions of keratinocyte cholinergic
signaling in CRC. receptors. J Investig Dermatol Symp Proc 1997;2:41-8.
17. Schlereth T, Birklein F, an Haack K, Schiffmann S, Kilbinger
H, Kirkpatrick CJ, Wessler I. In vivo release of non-neuronal
Another important aspect of MR signaling in CRC is acetylcholine from the human skin as measured by dermal
therapeutic potential of MR-based therapy. Because M1R microdialysis: effect of botulinum toxin. Br J Pharmacol
and M3R are both expressed abundantly in the intestinal 2006;147:183-7.
epithelium, buy have distinct functions, it is critical to 18. Song P, Sekhon HS, Jia Y, Keller JA, Blusztajn JK, Mark GP, Spindel
[45]
develop M1R- and M3R-specifc ligands, and test their ER. Acetylcholine is synthesized by and acts as an autocrine growth
factor for small cell lung carcinoma. Cancer Res 2003;63:214-21.
pharmacological and therapeutic characteristics both 19. Tsuji S, Anglade P. Acetylcholine in neurons and paraneurons: a
in vitro and in vivo. These studies will lay important histochemical study. Arch Histol Cytol 1989;52:75-83.
foundations for future human clinical trials that are focused 20. Keely SJ. Epithelial acetylcholine -- a new paradigm for cholinergic
on MR-based therapy. In addition, colon-specific drug regulation of intestinal fluid and electrolyte transport. J Physiol
delivery systems should be utilized to reduce unwanted 2011;589:771-2.
[49]
systemic side-effects. 21. Rosas-Ballina M, Olofsson PS, Ochani M, Valdés-Ferrer SI, Levine
YA, Reardon C, Tusche MW, Pavlov VA, Andersson U, Chavan
Financial support and sponsorship S, Mak TW, Tracey KJ. Acetylcholine-synthesizing T cells relay
neural signals in a vagus nerve circuit. Science 2011;334:98-101.
This work was supported by Merit Review Awards from 22. Brandon EP, Lin W, D’Amour KA, Pizzo DP, Dominguez B,
the United States Department of Veterans Affairs Program Sugiura Y, Thode S, Ko CP, Thal LJ, Gage FH, Lee KF. Aberrant
(G. Xie and J. P. Raufman) and NIH R21-DK093406 and patterning of neuromuscular synapses in choline acetyltransferase-
T32 DK067872 (J. P. Raufman). deficient mice. J Neurosci 2003;23:539-49.
23. Klapproth H, Reinheimer T, Metzen J, Münch M, Bittinger F,
Conflicts of interest Kirkpatrick CJ, Höhle KD, Schemann M, Racké K, Wessler I.
There are no conflicts of interest. Non-neuronal acetylcholine, a signalling molecule synthezised
by surface cells of rat and man. Naunyn Schmiedebergs Arch
Pharmacol 1997;355:515-23.
REFERENCES 24. Cheng K, Samimi R, Xie G, Shant J, Drachenberg C, Wade M, Davis
RJ, Nomikos G, Raufman JP. Acetylcholine release by human colon
1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. cancer cells mediates autocrine stimulation of cell proliferation. Am
Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87-108. J Physiol Gastrointest Liver Physiol 2008;295:G591-7.
2. Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. 25. von Rosenvinge EC, Cheng K, Drachenberg CB, Fowler CB, Evers
CA Cancer J Clin 2014;64:104-17. DL, Xie G, Raufman JP. Bedside to bench: role of muscarinic
3. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer receptor activation in ultrarapid growth of colorectal cancer in a
J Clin 2015;65:5-29. patient with pheochromocytoma. Mayo Clin Proc 2013;88:1340-6.
4. Modjtahedi H, Essapen S. Epidermal growth factor receptor 26. Raufman JP, Zimniak P, Bartoszko-Malik A. Lithocholyltaurine
inhibitors in cancer treatment: advances, challenges and interacts with cholinergic receptors on dispersed chief cells from
opportunities. Anticancer Drugs 2009;20:851-5. guinea pig stomach. Am J Physiol 1998;274:G997-1004.
5. Overman MJ, Hoff PM. EGFR-targeted therapies in colorectal 27. Raufman JP, Chen Y, Cheng K, Compadre C, Compadre L, Zimniak
cancer. Dis Colon Rectum 2007;50:1259-70. P. Selective interaction of bile acids with muscarinic receptors: a
6. Ilyas M. Wnt signalling and the mechanistic basis of tumour case of molecular mimicry. Eur J Pharmacol 2002;457:77-84.
development. J Pathol 2005;205:130-44. 28. Cheng K, Khurana S, Chen Y, Kennedy RH, Zimniak P, Raufman JP.
7. Wess J. Molecular biology of muscarinic acetylcholine receptors. Lithocholylcholine, a bile acid/acetylcholine hybrid, is a muscarinic
Crit Rev Neurobiol 1996;10:69-99. receptor antagonist. J Pharmacol Exp Ther 2002;303:29-35.
8. Wess J. Muscarinic acetylcholine receptor knockout mice: novel 29. Cheng K, Chen Y, Zimniak P, Raufman JP, Xiao Y, Frucht H.
phenotypes and clinical implications. Annu Rev Pharmacol Toxicol Functional interaction of lithocholic acid conjugates with M3
2004;44:423-50. muscarinic receptors on a human colon cancer cell line. Biochim
9. Shah N, Khurana S, Cheng K, Raufman JP. Muscarinic receptors and Biophys Acta 2002;1588:48-55.
ligands in cancer. Am J Physiol Cell Physiol 2009;296:C221-32. 30. Cheng K, Raufman JP. Bile acid-induced proliferation of a human
10. Spindel ER. Muscarinic receptor agonists and antagonists: effects colon cancer cell line is mediated by transactivation of epidermal
on cancer. Handb Exp Pharmacol 2012;208:451-68. growth factor receptors. Biochem Pharmacol 2005;70:1035-47.
11. Spindel ER. Cholinergic targets in lung cancer. Curr Pharm Des 31. Cheng K, Zimniak P, Raufman JP. Transactivation of the epidermal
2016;22:2152-9. growth factor receptor mediates cholinergic agonist-induced
12. Kruse AC, Kobilka BK, Gautam D, Sexton PM, Christopoulos A, proliferation of H508 human colon cancer cells. Cancer Res
Wess J. Muscarinic acetylcholine receptors: novel opportunities for 2003;63:6744-50.
drug development. Nat Rev Drug Discov 2014;13:549-60. 32. Raufman JP, Chen Y, Zimniak P, Cheng K. Deoxycholic acid
Journal of Cancer Metastasis and Treatment ¦ Volume 2 ¦ June 15, 2016 ¦ 199